Consumer Marketing briefs

Share this article:
The American College of Physicians (ACP) called for the FDA to be empowered to label newer drugs as such and to restrict consumer advertising of them. In a policy paper titled Improving FDA Regulation of Prescription Drugs, the group said the agency needs more funding and greater powers, including authorization to require that new drugs carry labeling indicating their new-to-market status and that DTC advertising be restricted for the first two years a drug is on the market.

Proctor & Gamble announced that Serena Williams would star in the latest iteration of its “Outsmart Mother Nature” print ad campaign for Tampax. Williams is pictured defeating Tampax's Mother Nature character, who tries to deliver her “monthly gift” in an attempt at throwing the tennis great off her game.

Myriad Genetics extended its hereditary breast cancer awareness campaign with ads in five Midwestern states in September. The campaign targets women—ages 25 to 54 with family or personal histories of breast or ovarian cancer—and their doctors, said Ogilvy, the campaign's PR firm. TV spots running on network channels through spring of 2010 will include branded messages for the BRACAnalysis test.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?